tiprankstipranks
Inovio Pharmaceuticals (INO)
NASDAQ:INO
US Market
INO
Inovio Pharmaceuticals
RESEARCH TOOLSreports

Inovio Pharmaceuticals (INO) Ratios

5,973 Followers

Inovio Pharmaceuticals Ratios

INO's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, INO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.40 1.40 2.77 3.60 3.25
Quick Ratio
 1.40 1.40 2.77 3.60 3.25
Cash Ratio
 1.01 1.01 1.86 0.34 0.48
Solvency Ratio
 -1.63 -1.63 -2.33 -2.46 -2.17
Operating Cash Flow Ratio
 -2.03 -2.03 -2.95 -2.92 -2.23
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 -7.42 0.00
Net Current Asset Value
$ 10.91M$ 10.91M$ 53.14M$ 99.51M$ 189.07M
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.10 0.18 0.09
Debt-to-Equity Ratio
 0.39 0.39 0.17 0.26 0.14
Debt-to-Capital Ratio
 0.28 0.28 0.15 0.20 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.07
Financial Leverage Ratio
 3.08 3.08 1.65 1.46 1.57
Debt Service Coverage Ratio
 0.00 0.00 -584.52 -7.25 -216.04
Interest Coverage Ratio
 0.00 0.00 -632.05 -117.71 -213.38
Debt to Market Cap
 0.00 0.00 0.00 0.12 0.04
Interest Debt Per Share
 0.02 0.02 0.44 1.42 1.68
Net Debt to EBITDA
 0.43 0.43 0.52 -0.12 0.05
Profitability Margins
Gross Profit Margin
-2189.03%100.00%100.00%100.00%100.00%
EBIT Margin
-130000.00%-130000.00%-49172.60%-16092.90%-2693.35%
EBITDA Margin
-125425.94%-125425.94%-47735.19%-15671.81%-2639.80%
Operating Profit Margin
-132871.32%-132871.32%-51616.91%-17300.28%-2607.35%
Pretax Profit Margin
-130000.00%-130000.00%-49254.27%-16239.87%-2726.67%
Net Profit Margin
-130000.00%-130000.00%-49254.27%-16239.87%-2726.67%
Continuous Operations Profit Margin
-130000.00%-130000.00%-49254.27%-16239.87%-2726.67%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
97.84%97.84%95.42%93.87%104.58%
Return on Assets (ROA)
-114.31%-114.31%-94.75%-79.04%-80.28%
Return on Equity (ROE)
-353.36%-352.53%-156.57%-115.14%-125.84%
Return on Capital Employed (ROCE)
-283.35%-283.35%-144.34%-112.12%-106.32%
Return on Invested Capital (ROIC)
-259.45%-259.45%-139.85%-97.55%-105.15%
Return on Tangible Assets
-114.31%-114.31%-94.75%-79.04%-83.31%
Earnings Yield
-16.03%-10.41%-215.78%-99.57%-75.17%
Efficiency Ratios
Receivables Turnover
 145.21 145.21 0.18 0.35 0.87
Payables Turnover
 0.57 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 <0.01 <0.01 0.02 0.06 0.57
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 0.03
Working Capital Turnover Ratio
 0.05 <0.01 <0.01 <0.01 0.03
Cash Conversion Cycle
 -636.63 2.51 2.01K 1.06K 417.50
Days of Sales Outstanding
 2.51 2.51 2.01K 1.06K 417.50
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 639.15 0.00 0.00 0.00 0.00
Operating Cycle
 2.51 2.51 2.01K 1.06K 417.50
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.19 -0.19 -3.83 -5.61 -10.87
Free Cash Flow Per Share
 -0.19 -0.19 -3.85 -5.62 -10.92
CapEx Per Share
 <0.01 <0.01 0.02 0.01 0.05
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -310.22 -310.22 -213.35 -387.55 -223.10
Capital Expenditure Coverage Ratio
 -310.22 -310.22 -213.35 -387.55 -223.10
Operating Cash Flow Coverage Ratio
 -9.46 -9.46 -8.77 -4.12 -6.74
Operating Cash Flow to Sales Ratio
 -1.36K -1.36K -477.95 -149.48 -21.07
Free Cash Flow Yield
-146.83%-10.90%-210.37%-91.88%-58.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -6.24 -9.60 -0.46 -1.00 -1.33
Price-to-Sales (P/S) Ratio
 926.75 12.49K 228.26 163.10 36.27
Price-to-Book (P/B) Ratio
 21.99 33.86 0.73 1.16 1.67
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.68 -9.18 -0.48 -1.09 -1.71
Price-to-Operating Cash Flow Ratio
 -5.98 -9.20 -0.48 -1.09 -1.72
Price-to-Earnings Growth (PEG) Ratio
 -0.22 0.18 0.01 0.02 >-0.01
Price-to-Fair Value
 21.99 33.86 0.73 1.16 1.67
Enterprise Value Multiple
 -0.31 -9.53 0.04 -1.16 -1.32
Enterprise Value
 25.65M 780.92M -4.24M 151.60M 358.00M
EV to EBITDA
 -0.31 -9.53 0.04 -1.16 -1.32
EV to Sales
 392.56 11.95K -19.49 182.21 34.88
EV to Free Cash Flow
 -0.29 -8.78 0.04 -1.22 -1.65
EV to Operating Cash Flow
 -0.29 -8.81 0.04 -1.22 -1.66
Tangible Book Value Per Share
 0.05 0.05 2.52 5.29 10.55
Shareholders’ Equity Per Share
 0.05 0.05 2.52 5.29 11.18
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 0.04 0.52
Net Income Per Share
 -0.18 -0.18 -3.95 -6.09 -14.07
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 1.01 1.01
Research & Development to Revenue
 824.12 829.57 347.27 104.18 18.29
SG&A to Revenue
 131.42K 500.14 169.90 57.19 8.79
Stock-Based Compensation to Revenue
 57.48 57.48 30.29 13.31 2.20
Income Quality
 1.04 1.04 0.97 0.92 0.77
Currency in USD